Bayer Plans to Separate to Benefit Company Growth

September 18, 2014
Pharmaceutical Technology Editors

Bayer separates into two entities to benefit the growth and development of Bayer Life Science and MaterialScience.

Bayer announced on Sept. 18, 2014 that it will divide into two global corporations: Bayer Life Science businesses and a separate identity, MaterialScience. The company-wide shift allows Bayer to focus time and the investments needed to sustain the Life Science businesses, which account for 70% of Bayer sales. According to Bayer, the plan to float MaterialScience independently on the stock market grants them direct access to capital for growth and will allow environmental and business development within the company.

Source: Bayer